| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 Mar 2025 | Direct | ||
| Adverum Biotechnologies, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | 09 Dec 2025 | 3 | $0 | 4 | Director | 10 Dec 2025, 13:27 |
| ADVM | Adverum Biotechnologies, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 16:22 |
| ATNM | Actinium Pharmaceuticals, Inc. | 31 Mar 2025 | 8 | $0 | 4 | Director | 02 Apr 2025, 18:21 |
| ADVM | Adverum Biotechnologies, Inc. | 17 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 16:49 |
| ATNM | Actinium Pharmaceuticals, Inc. | 28 Dec 2023 | 1 | $0 | 4 | Director | 29 Dec 2023, 17:24 |
| ADVM | Adverum Biotechnologies, Inc. | 03 Nov 2023 | 1 | $0 | 4 | Director | 06 Nov 2023, 19:54 |
| ADVM | Adverum Biotechnologies, Inc. | 03 Nov 2023 | 0 | $0 | 3 | Director | 06 Nov 2023, 19:52 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 19:17 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Sep 2021 | 1 | $0 | 4 | Director | 03 Sep 2021, 17:00 |